Across TCGA pan-cancer cohorts, RNA5SP338 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNA5SP338’s most consistent transcriptional readouts.
The strongest signal is observed in stomach adenocarcinoma (STAD), where RNA5SP338 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNA5SP338 is over-expressed in tumor.
STAD and KICH are the cancer types where RNA5SP338 tumor–normal differential expression is most reproducible.